Skip to main content
. Author manuscript; available in PMC: 2017 Jul 5.
Published in final edited form as: Mol Pharm. 2016 Feb 29;13(7):2148–2154. doi: 10.1021/acs.molpharmaceut.5b00905

Figure 4.

Figure 4

Activation level of VEGFR-2 normalized to the value for “no VEGF”. HUVECs were exposed to 20 ng/mL VEGF, except in the control condition, “No VEGF”. In addition, cells were cultured in the presence of 1 μM of alginate or alginate sulfates (DSsulfate = 5.3%) (*p < 0.05 with respect to the condition to expose HUVECs to bare VEGF).